Medtronic Total Other Countries Excluding United Statesand Ireland — Net Sales increased by 1.8% to $4.49B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $4.03B to $4.49B. Over 4 years (FY 2021 to FY 2025), Total Other Countries Excluding United Statesand Ireland — Net Sales shows an upward trend with a 3.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful expansion into international healthcare markets and growing global demand for the company's medical technology, while a decrease may signal competitive pressure, regulatory hurdles, or unfavorable macroeconomic conditions in foreign territories.
This metric represents the total revenue generated from the sale of medical devices and therapeutic solutions in geograp...
Peers in the medical device industry typically report international revenue as a percentage of total sales, with large-cap companies often targeting a balanced split between domestic and international contributions.
mdt_segment_rest_of_world_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.87B | $3.86B | $3.82B | $3.80B | $3.27B | $3.58B | $3.49B | $3.64B | $3.89B | $3.75B | $3.78B | $3.94B | $3.93B | $3.80B | $4.07B | $4.03B | $4.70B | $4.32B | $4.41B | $4.49B |
| QoQ Change | — | -0.4% | -1.0% | -0.6% | -13.9% | +9.4% | -2.5% | +4.3% | +6.7% | -3.5% | +0.8% | +4.3% | -0.3% | -3.2% | +7.0% | -1.1% | +16.8% | -8.1% | +2.1% | +1.8% |
| YoY Change | — | — | — | — | -15.5% | -7.2% | -8.7% | -4.2% | +18.7% | +4.7% | +8.3% | +8.2% | +1.1% | +1.4% | +7.7% | +2.2% | +19.7% | +13.6% | +8.4% | +11.4% |